Retatrutide Peptide Cost in 2026: What Researchers Actually Pay Per Milligram

If you searched “how much does retatrutide cost” expecting a pharmacy price or a monthly subscription figure, you will not find one here. No retail price exists because no approved product exists. Retatrutide (LY3437943) is investigational. It is in Phase 3 TRIUMPH trials. FDA approval is not expected before 2027 to 2028.

What does exist in 2026 is research-grade Retatrutide, supplied as lyophilized powder in sealed vials for in vitro laboratory and preclinical research use. That is the only legal, accessible form of this compound right now, and that is what this guide covers.

There Are Three Ways People Access Retatrutide in 2026. Only One is Straightforward.

Clinical Trials

The cleanest route. Eli Lilly covered the compound, monitoring, and labs for enrolled participants. The catch is that most major TRIUMPH trial arms closed enrollment in 2025. New sub-studies occasionally open on ClinicalTrials.gov, but do not rely on this as a practical access route in 2026.

Compounded Retatrutide

Advertised by some telehealth platforms at $300 to $600 per month. The legal position here is genuinely murky. Retatrutide was never on the FDA drug shortage list because it was never approved, so compounders offering it operate under far more tenuous legal framing than those that handled semaglutide or tirzepatide during the 2023 to 2024 shortages. The FDA issued warning letters in September 2025 to vendors selling research peptides while including human dosing instructions and marketing them for weight loss.

RUO Research Peptides

The straightforward option for laboratory researchers. These are legally supplied as research reagents for in vitro and preclinical use, priced per vial and per milligram, with batch-specific Certificates of Analysis from independent testing laboratories. This is what the rest of this guide covers.

How Retatrutide Research Peptide Pricing Actually Works

Most people look at the vial price. Researchers should look at the cost per milligram.

A vial labeled 20mg does not always contain exactly 20mg of usable peptide. Lyophilized peptides carry counter-ions from the synthesis process that add mass. The confirmed net peptide content, which a reputable supplier verifies through independent HPLC testing, is the number that actually matters for your concentration calculations and your budget.

A supplier quoting a low vial price without a third-party COA confirming net peptide content is not necessarily cheaper. They may be giving you less peptide per dollar than a higher-priced vial with confirmed net content.

The other variable is purity. Market-wide data from Q1 2026 tracked 148 Retatrutide observations across 5 vendors, with a median cost of $6.37 per milligram, the widest absolute price range of any peptide tracked in that dataset. That range exists because purity verification, net content confirmation, and sourcing quality vary significantly between suppliers.

Retatrutide RUO Cost Per Milligram: Profound Peptides Lineup (2026)

Here is the cost breakdown across our four vial sizes, using confirmed net peptide content from Freedom Diagnostics batch testing.

Vial Size	Price	Confirmed Net Content	Cost Per mg
Retatrutide RUO 10mg	$90	13.00mg	$6.92/mg
Retatrutide RUO 20mg	$140	27.31mg	$5.13/mg
Retatrutide RUO 40mg	$220	49.66mg	$4.43/mg
Retatrutide RUO 60mg	$325	55.67mg	$5.84/mg

The 40mg vial is the lowest cost per milligram in the lineup at $4.43/mg, making it the most economical choice for labs that have already confirmed their dosing protocol. The 60mg vial comes in slightly higher per milligram than the 40mg because the confirmed net content of 55.67mg is proportionally lower relative to price. That is a batch-specific outcome, not a pricing structure issue. The 60mg batch compensates with the highest purity result in the lineup at 99.96%.

Every figure in the table is based on confirmed net peptide content from independent Freedom Diagnostics COA testing, not the labeled vial mass.

What Purity Verification Actually Adds to the Cost

The market median of $6.37 per milligram includes vendors whose COAs come from in-house testing and vendors whose COAs come from fully independent laboratories. Those are not equivalent.

Profound Peptides uses Freedom Diagnostics, a US-owned independent laboratory. Results are publicly searchable on FreedomDiagnosticsTesting.com using the batch accession number. No contact with us is required to verify a result. That independence is what the COA is worth.

Purity results across the current Retatrutide lineup: 99.914% on the 10mg batch, 99.86% on the 20mg, 99.689% on the 40mg, and 99.96% on the 60mg. All four sit well above the 98% threshold that most published preclinical Retatrutide studies use as a minimum specification.

What a Full Research Protocol Actually Costs

This is the calculation most pricing guides skip.

Short Protocol Example

A standard 12-week rodent metabolic study with three treatment arms, eight animals per arm, dosed at 1mg/kg once weekly in 25g mice. Total peptide consumption across 12 weeks works out to approximately 7.2mg. A single 10mg vial covers that with stock to spare for dose adjustments and satellite assays.

Extended Protocol Example

Four treatment arms, 10 animals each, dosed at 2mg/kg twice weekly in 30g mice over 24 weeks. Total consumption is approximately 57.6mg. That sits right at the confirmed net content of the 60mg vial, with one lot number covering your entire study.

Why Batch Consistency Matters More Than Price Per Milligram

The cost of reordering mid-study is not just the price of a second vial. It is the inter-batch variability risk. Two vials from different lots introduce a potential confounding variable into dose-response data. For studies where reproducibility is the point, one vial from one batch is worth more than the per-milligram savings from buying smaller. If your protocol sits somewhere between those two examples, the 20mg and 40mg formats cover the middle ground with the same batch-consistency logic.

For context, not for research budgeting.

Tirzepatide launched as Mounjaro in 2022 at approximately $1,023 per month. When Eli Lilly introduced Zepbound for obesity in late 2023, it launched at around $1,060 per month. By December 2025, Eli Lilly announced significant price reductions through its Self-Pay Journey Program, bringing Zepbound down to $299 to $449 per month depending on dose.

Post-approval list pricing for Retatrutide is projected at $1,100 to $1,400 per month based on market comparisons, though out-of-pocket costs will depend on insurance coverage and savings programs that do not yet exist.

FDA approval is not expected before late 2027 at the earliest, based on the expected NDA filing timeline following Phase 3 completion.What Will Retatrutide Cost After FDA Approval?

The Bottom Line for Researchers

Retatrutide RUO research peptide costs between $4.43 and $6.92 per milligram from Profound Peptides in 2026, depending on vial size. The right vial is not necessarily the cheapest per milligram. It is the one whose confirmed net content covers your full protocol from a single batch, with a publicly verifiable COA from an independent laboratory.

If you are planning a study and want to work out which vial size fits your specific protocol, the spec sheet and COA details for each format are on the individual product pages.

All Retatrutide RUO products from Profound Peptides are for in vitro laboratory and scientific research use only. Not for human consumption, veterinary use, or diagnostic purposes.